Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
17 studies found for:    HIV AND "treatment naive" | Open Studies | HIV
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Safety and Efficacy of MK-1439A in Participants Infected With Treatment-Naïve Human Immunodeficiency Virus (HIV) -1 With Transmitted Resistance (MK-1439A-030)
Condition: HIV-1 Infection
Intervention: Drug: MK-1439A
2 Recruiting An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 2)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir (DTG);   Drug: Lamivudine (3TC);   Drug: Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC)
3 Recruiting An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir (DTG);   Drug: Lamivudine (3TC);   Drug: Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC)
4 Recruiting Impact of Starting a Dolutegravir-based Regimen on HIV-1 Proviral DNA Reservoir Of Treatment Naïve and Experienced Patients
Condition: HIV-1 Infection
Intervention: Biological: Blood samples
5 Recruiting Dolutegravir Plus Lamivudine Dual Therapy in Treatment Naïve HIV-1 Patients
Condition: HIV-1 Infection
Interventions: Drug: Dolutegravir;   Drug: Lamivudine
6 Recruiting A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects
Condition: Immunodeficiency Virus Type 1, Human
Interventions: Drug: Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC;   Drug: DRV/COBI FDC;   Drug: FTC/TDF FDC;   Drug: D/C/F/TAF FDC - Matching Placebo;   Drug: FTC/TDF FDC Matching Placebo;   Drug: DRV/COBI FDC Matching Placebo
7 Recruiting Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals
Condition: HIV Infection
Intervention: Drug: Polyphenon E
8 Not yet recruiting An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens in Aged HIV Patients (RalAge)
Condition: HIV
Intervention: Other: Observational retrospective cohort to describe RAL data
9 Recruiting Resistance in HIV+ in North and South
Condition: HIV Drug Resistance
Intervention:
10 Recruiting Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa
Conditions: Hepatitis C;   HIV Infection
Interventions: Drug: Sofosbuvir;   Drug: Ribavirin;   Drug: Ledipasvir
11 Recruiting Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials
Condition: HIV Infections
Intervention:
12 Recruiting Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial
Condition: HIV
Intervention: Drug: alendronate/vitamin D
13 Not yet recruiting Digital Health Feedback System for Longitudinal Measurement of Medication Adherence During Initial ARV Therapy
Condition: HIV
Intervention: Device: Digital Health Feedback System
14 Recruiting A Prospective Cohort of Children With HIV Infection
Condition: HIV Infections
Interventions: Drug: Zidovudine, Stavudine, Didanosine, Lamivudine;   Drug: Nevirapine, Efavirenz;   Drug: LPV/r, Saquinavir, Indinavir, Ritonavir, Nelfinavir
15 Recruiting Oral Human Papillomavirus Infection in HIV-infected Men
Conditions: Papillomavirus Infections;   HIV Infections
Intervention: Procedure: Oral swabs for HPV-typing and high-risk HPV-determination
16 Recruiting Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Primary and Chronic HIV-Infected Patients
Condition: HIV
Intervention:
17 Recruiting Intensive Models of HCV Care for Injection Drug Users
Conditions: Hepatitis C;   Medication Adherence
Intervention: Other: Intensive Models (mDOT and CGT) of HCV Care

Study has passed its completion date and status has not been verified in more than two years.